Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$604,297,889
-$1,901,674,569 QoQ
Shares Held
1,668,778
-76.6% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#37
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. AMGN ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $604,297,889 | 1,668,778 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,505,972,458 | 7,122,275 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,952,548,033 | 18,186,270 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,416,263,189 | 19,192,995 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,280,077,766 | 18,910,776 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,715,267,190 | 15,134,865 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,182,952,621 | 12,212,065 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,808,563,442 | 8,716,562 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,618,006,052 | 8,378,960 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,991,738,082 | 7,005,269 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $311,451,579 | 1,081,354 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $199,645,409 | 742,839 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $128,430,799 | 578,465 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $139,817,563 | 578,356 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $151,851,619 | 578,174 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $130,264,069 | 577,924 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $140,590,905 | 577,850 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $153,552,798 | 634,988 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $582,640,804 | 2,589,860 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $550,683,756 | 2,589,625 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $526,312,800 | 2,159,232 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $490,018,854 | 1,969,450 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $538,147,533 | 2,340,586 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $787,904,133 | 3,100,032 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $969,483,661 | 4,110,420 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,155,639,456 | 5,700,387 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||